FDA approves Calypte's HIV-1 urine test:
This article was originally published in Clinica
Calypte Biomedical has received US FDA approval for its HIV-1 urine test. Calypte HIV-1 Urine EIA/Sentinel HIV-1 Urine EIA will be available in public health clinics, hospitals and doctors' offices. Dr Luc Montagnier, discoverer of the HIV-1 virus and a member of Calypte's scientific board, says the urine test will be particularly important in developing countries where access to clean needles for drawing blood is not always available. Confirmatory testing using blood samples will be required. Seradyne, a US diagnostics company based in Indiana, will distribute the urine test in the UK.